Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
16.12 USD | +2.06% | -2.66% | -9.60% |
05:39pm | HC Wainwright Adjusts Price Target on REGENXBIO to $38 From $36, Maintains Buy Rating | MT |
09/05 | UBS Adjusts Price Target on REGENXBIO to $39 From $43, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.60% | 778M | |
+7.64% | 111B | |
+11.19% | 106B | |
-12.20% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.73% | 16.81B | |
+38.61% | 12.54B | |
-24.40% | 8.09B |
- Stock Market
- Equities
- RGNX Stock
- News REGENXBIO Inc.
- RBC Capital Adjusts REGENXBIO's Price Target to $29 from $47, Maintains Sector Perform Rating